 |
cytomegalovirus specific cytotoxic T lymphocytes |
|---|---|
| Trade Name | |
| Orphan Indication | Cytomegalovirus infection in severely immunocompromised patients |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-05 00:00:00 |
| Sponsor | ViraCyte, LLC;33 - 5th Avenue, NW, Suite 700;New Brighton, Minnesota, 55112 |
